Sale!

TRIOBP Gene Deafness Autosomal Recessive Type 28 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TRIOBP Gene Deafness Autosomal Recessive Type 28 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the TRIOBP gene, which are linked to a specific form of genetic hearing loss known as Autosomal Recessive Deafness Type 28 (DFNB28). This condition is characterized by the inheritance of two copies of the mutated gene, one from each parent, leading to early-onset sensorineural hearing loss, which affects the inner ear or nerve pathways to the brain.

The test is conducted through a detailed analysis of the patient’s DNA, extracted from a blood sample, to search for the specific genetic alterations within the TRIOBP gene that are known to cause this type of hearing loss. It is particularly recommended for individuals with a family history of hearing impairment or parents planning to have children who may be at risk of inheriting the condition.

Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers a comprehensive approach to diagnosing this rare form of deafness. The cost of the test is set at 4400 AED, reflecting the intricate laboratory work and expert analysis required to accurately identify the genetic mutation responsible for the condition. This test not only aids in the diagnosis but also helps in the management and planning for the needs of individuals affected by Autosomal Recessive Deafness Type 28, providing essential information for families and healthcare providers.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TRIOBP Gene Deafness Autosomal Recessive Type 28 Genetic Test

Welcome to DNA Labs UAE, your trusted genetic testing laboratory in the UAE. We offer the TRIOBP Gene Deafness Autosomal Recessive Type 28 Genetic Test at a cost of AED 4400.0.

Test Details

The TRIOBP gene is associated with a type of deafness known as autosomal recessive type 28 (DFNB28). This means that an individual must inherit two copies of the mutated gene, one from each parent, in order to develop the condition.

Our genetic testing method, Next-Generation Sequencing (NGS) Technology, allows for the analysis of multiple genes simultaneously. In the context of deafness, NGS can be used to identify mutations in the TRIOBP gene, among others, to help diagnose the underlying cause of an individual’s hearing loss.

Test Components and Price

  • Test Name: TRIOBP Gene Deafness Autosomal Recessive Type 28 Genetic Test
  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: AED 4400.0

Report Delivery

Once the sample is received, the report will be delivered within 3 to 4 weeks.

Test Type and Doctor

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department

Test Department: Genetics

Pre Test Information

Before undergoing the TRIOBP Gene Deafness Autosomal Recessive Type 28 Genetic Test, it is important to provide the clinical history of the patient who is going for the EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with the EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA8.

About the TRIOBP Gene

The TRIOBP gene provides instructions for making a protein called TRIO and F-actin binding protein (TRIOBP). This protein is involved in the development and maintenance of hair cells in the inner ear, which are responsible for detecting sound and transmitting signals to the brain. Mutations in the TRIOBP gene can disrupt the normal function of these hair cells, leading to hearing loss.

Genetic Testing for DFNB28

Genetic testing for DFNB28 can help confirm a diagnosis of autosomal recessive deafness and provide information about the specific mutation in the TRIOBP gene. This information can be valuable for genetic counseling, as it can help determine the likelihood of passing the condition on to future generations and guide treatment options.

It is important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor, who can help interpret the results and provide appropriate recommendations based on an individual’s specific situation.

Test Name TRIOBP Gene Deafness autosomal recessive type 28 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA8
Test Details

The TRIOBP gene is associated with a type of deafness known as autosomal recessive type 28 (DFNB28). Autosomal recessive means that an individual must inherit two copies of the mutated gene, one from each parent, in order to develop the condition.

NGS (Next-Generation Sequencing) is a genetic testing method that allows for the analysis of multiple genes simultaneously. In the context of deafness, NGS can be used to identify mutations in the TRIOBP gene, among others, to help diagnose the underlying cause of an individual’s hearing loss.

The TRIOBP gene provides instructions for making a protein called TRIO and F-actin binding protein (TRIOBP). This protein is involved in the development and maintenance of hair cells in the inner ear, which are responsible for detecting sound and transmitting signals to the brain. Mutations in the TRIOBP gene can disrupt the normal function of these hair cells, leading to hearing loss.

Genetic testing for DFNB28 can help confirm a diagnosis of autosomal recessive deafness and provide information about the specific mutation in the TRIOBP gene. This information can be valuable for genetic counseling, as it can help determine the likelihood of passing the condition on to future generations and guide treatment options.

It is important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor, who can help interpret the results and provide appropriate recommendations based on an individual’s specific situation.